Objective: To assess the anti-cancer capacity of vitamin D in head and neck squamous cell carcinoma cell line. Materials and Methods: vitamin D cytotoxic effect and cell apoptosis effect were evaluated using Prestoblue cell viability assay and Flow Cytometry. Results: Vitamin D was found to inhibit the cell growth in a dose-dependent manner in head and neck squamous cell carcinoma JHU-29 cell line at three days' treatment. However, it was not found to cause significant apoptosis at one day treatment. Conclusion: vitamin D inhibits the growth of head and neck squamous cell carcinoma in a dose-dependent manner.
INTRODUCTION
Head and neck malignancy is one of the most commonly diagnosed malignancies worldwide. Patients with advanced disease stages frequently develop either recurrences or distant metastasis, which result in a five-year survival rates of nearly 50% in spite of the considerable advances in multimodality treatment. Therefore, a better understanding of the molecular basis of carcinogenesis is required to develop novel diagnostic biomarkers, and to develop new anti-cancer therapies
The active vitamin D metabolite calcitriol has many functions besides its classical biological effects on calcium and phosphorus homeostasis. Calcitriol has a broad variety of actions including anticancer effects that are mediated either transcriptionally or via non-genomic pathways. In cancer, calcitriol regulates the cell cycle, induces apoptosis, promotes cell differentiation and acts as anti-inflammatory factor within the tumor microenvironment (2) .
Current cancer therapies have many side effects which may include facial disfigurement. That necessitated the search for more anti-cancer 
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MATERIALS AND METHODS
All cells were grown as adhesive monolayers in a humidified atmosphere of 5% CO 2 in air at 37°C (2). The medium components included: RPMI 1640 medium fortified with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1% Sodium Pyruvate, 1% MEM Nonessential amino acids, and 1% L-glutamate. Cells in the current experiment were sub-cultured every other day using 0.05% trypsin for two minutes.
PrestoBlue cell viability assay
Cells were seeded at an initial density of 5000 cells per well in a flat-bottom 96-well cell culture plate and allowed to grow in 200 ul growth medium per well for 24 hours in a humidified 5% CO 2 , 95% air atmosphere in an incubator kept at 37 o C. The old medium was aspirated, and 200 ul of vitaminmedium mixture was added in concentrations of 10 -6 , 10 -8 and 10 -9 M in six replicates for each concentration to compensate for technical errors. Medium with 0.1% DMSO was added to other six replicates as a control. The cells were incubated for other three days.
Prestoblue solution (PrestoBlue Cell Viability Reagent was manufactured by Thermo Fisher Scientific Inc.) was added according to the manufacturer's instructions. The plate was scanned with an OptiMax microplate reader (VersaMax microplate reader by Molecular Devices, Sunnyvale, CA.) at an absorbance mood using an excitation wavelength of 560 nm and an emission wavelength of 600 nm.
The data was converted into the relative cell viability (%) from the absorbance of cells in each treatment concentration relative to that in the solvent only control group (set as 100%).
Flow cytometry to analyze cell apoptosis:
Cell apoptosis was analyzed using a flow cytometer with FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, San Diego, CA). One day after treatment with 1,25(OH) 2 D3 or DMSO vehicle, or ethanol. Cell apoptosis was analyzed. Pelleted cells from each sample were washed twice with cold PBS then resuspended in 1X binding buffer diluted with nine parts distilled water at a concentration of 1 x 10 6 cells/ml. Cells from each sample were separated into four tubes. Each tube was received either a 5 ul of FITC Annexin or 5 ul Propidium Iodide (PI) or both or neither, and then incubated at room temperature for 15 min in the dark. Another 400 ul binding buffer was added to each tube. Samples were transferred into flow cytometry tubes and analyzed within one hour using a flow cytometer BD (FACSVerse manufactured by BD Biosciences, San Diego, CA.). The cell population was divided into three groups: live cells, apoptotic cells in the earlier period (Annexin V positive), and necrotic and advanced stage apoptotic cells (Annexin V and PI positive). The aim of the current study was to investigate the anti-cancer potential of 1,25(OH) 2 D3 on head and neck cancer cell line. Flow cytometry results did not show a significant difference in apoptotic cells between treated and untreated groups. This may be due to the short treatment duration of one day.
RESULTS
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Further in vitro and in vivo animal studies are needed to detrmine the mechanisms of vitamin D anti-cancer effects and to determine the therapuetic doses needed. 
